BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
themis medicare ltd. stock

THEMIS MEDICARE LTD. Share Price

291.1 0.00 (0.00%)
Dec 11 2024 12:00 AM Pharmaceuticals NSE: THEMISMED

THEMIS MEDICARE LTD. Share Price Update

As of the latest trading session, THEMIS MEDICARE LTD. share price is currently at 291.1, which is up by 0.00 from its previous closing. Today, the stock has fluctuated between 288.65 and 294.50. Over the past year, THEMIS MEDICARE LTD. has achieved a return of 62.66 %. In the last month alone, the return has been 5.59 %. Read More...

THEMIS MEDICARE LTD. Performance

Day Range

Low288.65 High294.50
291.10

52 Week Range

Low 168.55 High 317.00
291.10

THEMIS MEDICARE LTD. Share Price

14485

530199

THEMISMED

img img img img
No Data Available

Open Price

290.55

Prev. Close

291.10

Volume (Shares)

67225.00

Total traded value

195.69

Upper Circuit

349.30

Lower Circuit

232.90

Note: The current prices & values are delayed, Login to your account for live updates.

THEMIS MEDICARE LTD. Fundamentals


(Standalone)

Market Cap (Cr) 2679.28
PE Ratio (TTM) 79.29
Book Value / Share 31.70
Beta 1.40
ROE 9.59%
EPS (TTM) 4.09
Dividend Yield 0.17%
Net Profit Qtr (Cr) 9.87

THEMIS MEDICARE LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 99.59
Operating Expense 85.22
Net Profit 9.87
Net Profit Margin (%) 9.91
Earnings Per Share (EPS) 1.08
EBITDA 17.79
Effective Tax Rate (%) 26.10
Particulars JUN 2024 (Values in Cr)
Revenue 106.08
Operating Expense 79.28
Net Profit 18.71
Net Profit Margin (%) 17.63
Earnings Per Share (EPS) 2.03
EBITDA 29.95
Effective Tax Rate (%) 26.18
Particulars MAR 2024 (Values in Cr)
Revenue 75.52
Operating Expense 69.69
Net Profit 3.09
Net Profit Margin (%) 4.09
Earnings Per Share (EPS) 0.34
EBITDA 9.33
Effective Tax Rate (%) 37.08
Particulars DEC 2023 (Values in Cr)
Revenue 82.51
Operating Expense 80.22
Net Profit 2.00
Net Profit Margin (%) 2.42
Earnings Per Share (EPS) 0.22
EBITDA 8.63
Effective Tax Rate (%) 29.82
Particulars SEP 2023 (Values in Cr)
Revenue 104.78
Operating Expense 97.49
Net Profit 7.10
Net Profit Margin (%) 6.77
Earnings Per Share (EPS) 8.28
EBITDA 14.85
Effective Tax Rate (%) 27.10
Particulars MAR 2024 (Values in Cr)
Revenue 287.52
Operating Expense 275.56
Net Profit 24.75
Net Profit Margin (%) 8.60
Earnings Per Share (EPS) 2.69
EBITDA 27.24
Effective Tax Rate (%) 32.62
Particulars MAR 2023 (Values in Cr)
Revenue 354.32
Operating Expense 306.92
Net Profit 43.29
Net Profit Margin (%) 12.21
Earnings Per Share (EPS) 47.05
EBITDA 78.96
Effective Tax Rate (%) 26.49
Particulars MAR 2022 (Values in Cr)
Revenue 394.61
Operating Expense 317.21
Net Profit 61.56
Net Profit Margin (%) 15.60
Earnings Per Share (EPS) 66.91
EBITDA 102.19
Effective Tax Rate (%) 26.66
Particulars MAR 2021 (Values in Cr)
Revenue 230.67
Operating Expense 202.04
Net Profit 26.62
Net Profit Margin (%) 11.54
Earnings Per Share (EPS) 28.97
EBITDA 53.51
Effective Tax Rate (%) 17.45
Particulars MAR 2020 (Values in Cr)
Revenue 201.59
Operating Expense 187.04
Net Profit 15.91
Net Profit Margin (%) 7.89
Earnings Per Share (EPS) 17.32
EBITDA 39.16
Effective Tax Rate (%) 11.60
Particulars MAR 2024 (Values in Cr)
Book Value / Share 37.41
ROE % 13.39
ROCE % 14.99
Total Debt to Total Equity 0.29
EBITDA Margin 19.66
Particulars MAR 2023 (Values in Cr)
Book Value / Share 332.15
ROE % 20.36
ROCE % 22.45
Total Debt to Total Equity 0.31
EBITDA Margin 26.13
Particulars MAR 2022 (Values in Cr)
Book Value / Share 275.34
ROE % 33.33
ROCE % 34.44
Total Debt to Total Equity 0.38
EBITDA Margin 28.77
Particulars MAR 2021 (Values in Cr)
Book Value / Share 200.18
ROE % 21.51
ROCE % 20.82
Total Debt to Total Equity 0.56
EBITDA Margin 27.13
Particulars MAR 2020 (Values in Cr)
Book Value / Share 161.14
ROE % 18.30
ROCE % 17.57
Total Debt to Total Equity 0.67
EBITDA Margin 23.83
Particulars MAR 2024 (Values in Cr)
Book Value / Share 29.11
ROE % 9.59
ROCE % 12.51
Total Debt to Total Equity 0.36
EBITDA Margin 14.74
Particulars MAR 2023 (Values in Cr)
Book Value / Share 269.54
ROE % 18.93
ROCE % 21.75
Total Debt to Total Equity 0.38
EBITDA Margin 22.28
Particulars MAR 2022 (Values in Cr)
Book Value / Share 227.50
ROE % 34.15
ROCE % 35.15
Total Debt to Total Equity 0.46
EBITDA Margin 25.90
Particulars MAR 2021 (Values in Cr)
Book Value / Share 164.59
ROE % 19.32
ROCE % 19.43
Total Debt to Total Equity 0.68
EBITDA Margin 23.19
Particulars MAR 2020 (Values in Cr)
Book Value / Share 135.33
ROE % 13.70
ROCE % 14.92
Total Debt to Total Equity 0.78
EBITDA Margin 19.42
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 19.29
Total Assets 566.41
Total Liabilities 566.41
Total Equity 377.66
Share Outstanding 92040120
Price to Book Ratio 7.52
Return on Assets (%) 7.68
Return on Capital (%) 9.19
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 18.88
Total Assets 513.95
Total Liabilities 513.95
Total Equity 339.44
Share Outstanding 9202770
Price to Book Ratio 4.33
Return on Assets (%) 11.07
Return on Capital (%) 13.19
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 26.49
Total Assets 427.78
Total Liabilities 427.78
Total Equity 287.48
Share Outstanding 9200270
Price to Book Ratio 4.10
Return on Assets (%) 17.03
Return on Capital (%) 19.91
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 24.63
Total Assets 371.14
Total Liabilities 371.14
Total Equity 218.50
Share Outstanding 9188454
Price to Book Ratio 1.70
Return on Assets (%) 9.61
Return on Capital (%) 11.76
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 5.29
Total Assets 349.91
Total Liabilities 349.91
Total Equity 183.02
Share Outstanding 9187992
Price to Book Ratio 1.77
Return on Assets (%) 7.08
Return on Capital (%) 9.13
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 19.20
Total Assets 489.96
Total Liabilities 489.96
Total Equity 301.27
Share Outstanding 92040120
Price to Book Ratio 7.52
Return on Assets (%) 5.05
Return on Capital (%) 6.23
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 18.85
Total Assets 456.28
Total Liabilities 456.28
Total Equity 281.82
Share Outstanding 9202770
Price to Book Ratio 4.33
Return on Assets (%) 9.48
Return on Capital (%) 11.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 26.48
Total Assets 383.73
Total Liabilities 383.73
Total Equity 243.48
Share Outstanding 9200270
Price to Book Ratio 4.10
Return on Assets (%) 16.04
Return on Capital (%) 19.12
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 24.62
Total Assets 338.40
Total Liabilities 338.40
Total Equity 185.80
Share Outstanding 9188454
Price to Book Ratio 1.70
Return on Assets (%) 7.86
Return on Capital (%) 9.82
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 5.28
Total Assets 326.17
Total Liabilities 326.17
Total Equity 159.31
Share Outstanding 9187992
Price to Book Ratio 1.77
Return on Assets (%) 4.87
Return on Capital (%) 6.42
Particulars MAR 2024 (Values in Cr)
Net Income 53.44
Cash from Operations 31.04
Cash from Investing -15.94
Cash from Financing -8.77
Net change in Cash -2.62
Free Cash Flow 49.46
Particulars MAR 2023 (Values in Cr)
Net Income 72.51
Cash from Operations 32.24
Cash from Investing -23.96
Cash from Financing 0.13
Net change in Cash -7.73
Free Cash Flow 60.99
Particulars MAR 2022 (Values in Cr)
Net Income 95.26
Cash from Operations 52.46
Cash from Investing -15.58
Cash from Financing -17.54
Net change in Cash 1.26
Free Cash Flow 73.09
Particulars MAR 2021 (Values in Cr)
Net Income 41.33
Cash from Operations 56.89
Cash from Investing -15.65
Cash from Financing -25.64
Net change in Cash 15.67
Free Cash Flow 74.93
Particulars MAR 2020 (Values in Cr)
Net Income 26.87
Cash from Operations 0.57
Cash from Investing -5.46
Cash from Financing 6.72
Net change in Cash 1.58
Free Cash Flow 6.37
Particulars MAR 2024 (Values in Cr)
Net Income 34.66
Cash from Operations 31.00
Cash from Investing -15.95
Cash from Financing -8.77
Net change in Cash -2.68
Free Cash Flow 49.41
Particulars MAR 2023 (Values in Cr)
Net Income 58.90
Cash from Operations 32.22
Cash from Investing -23.96
Cash from Financing 0.13
Net change in Cash -7.75
Free Cash Flow 60.97
Particulars MAR 2022 (Values in Cr)
Net Income 83.93
Cash from Operations 52.46
Cash from Investing -15.58
Cash from Financing -17.54
Net change in Cash 1.26
Free Cash Flow 73.09
Particulars MAR 2021 (Values in Cr)
Net Income 32.24
Cash from Operations 56.89
Cash from Investing -15.65
Cash from Financing -25.64
Net change in Cash 15.67
Free Cash Flow 74.93
Particulars MAR 2020 (Values in Cr)
Net Income 18.00
Cash from Operations 0.57
Cash from Investing -5.45
Cash from Financing 6.72
Net change in Cash 1.59
Free Cash Flow 6.37
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 37.87 3.59 505.01 37.54 / 77.70
BLISS GVS PHARMA LTD 155.50 19.46 1.62 1637.91 92.25 / 172.40
CIPLA LTD 1455.65 25.47 4.14 117560.12 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 414.95 144.08 4.20 1221.24 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 57.30 11.20 505.01 37.54 / 77.70
AMRUTAJAN HEALTH LTD 753.60 45.84 7.31 2178.71 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6634.15 128.84 24.41 16585.38 4050.15 / 8139.85
BLISS GVS PHARMA LTD 155.50 20.27 1.59 1637.91 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 291.70
  • 26 Days 284.10
  • 10 Days 292.00
  • 50 Days 282.50
  • 12 Days 291.30
  • 100 Days 267.10
  • 20 Days 287.80
  • 200 Days 242.80
291.78
PIVOT
First Resistance 295.22
Second Resistance 298.93
Third Resistance 302.37
First Support 288.07
Second Support 284.63
Third Support 280.92
RSI 55.84
MACD 7.21
Commodity Channel Index (CCI) 38.96
ADX 25.58
Williams % R -63.35

Over 1 Month

down

5.59

Over 3 Months

down

16.71

Over 6 Months

down

34.76

Over 1 Year

down

62.66

Over 3 Years

down

44.81

Over 5 Years

down

61.78

THEMIS MEDICARE LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

THEMIS MEDICARE LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
30.3
Promoter Holdings
67.14
FII
0.09
DII
0.01
Promoter Shares(Pledge Percentage)
2.43
Name Category Shares Shares%
Vividhmargi Investments Pvt Shareholding of Promoter and Promoter Group 1.452842E7 15.78
Gedeon Richter Investment Management Ltd. Shareholding of Promoter and Promoter Group 8843080.0 9.61
Dinesh Shantilal Patel Shareholding of Promoter and Promoter Group 8720570.0 9.47
Vividh Distributors Pvt Ltd Shareholding of Promoter and Promoter Group 7161000.0 7.78
Jayshree D Patel Shareholding of Promoter and Promoter Group 6676640.0 7.25
Sachin Dinesh Patel Shareholding of Promoter and Promoter Group 5516550.0 5.99
Anuj Anantrai Sheth Public Shareholding 4461519.0 4.85
Reena S Patel Shareholding of Promoter and Promoter Group 3714910.0 4.04
Themis Distributors Private Limited Shareholding of Promoter and Promoter Group 2740040.0 2.98
Zafar Ahmadullah Public Shareholding 2153900.0 2.34
Za Capital Services India Private Ltd Public Shareholding 1411893.0 1.53
Jagat Navratna Lodha Public Shareholding 1217500.0 1.32
Nysha Rupen Choksi Shareholding of Promoter and Promoter Group 1176890.0 1.28
Anay Rupen Choksi Shareholding of Promoter and Promoter Group 1176890.0 1.28
Dinesh S Patel Huf Shareholding of Promoter and Promoter Group 989000.0 1.07
Shantilal Dahyabhai Patel (huf) Shareholding of Promoter and Promoter Group 558000.0 0.61
Rupen Ashwin Choksi Shareholding of Promoter and Promoter Group 2000.0 0.0

THEMIS MEDICARE LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-01 5.0 Final 2023-09-02 Equity shares 2022-09-08 5.0 Final 2022-09-12 Equity shares 2021-09-08 4.3 Final 2021-09-11 Equity shares 2020-09-17 1.75 Final 2020-09-21 Equity shares 2011-07-20 3.0 Final 2011-07-22 Equity shares 2010-06-16 3.0 Final 2010-06-18 Equity shares 2008-08-01 2.5 Final 2008-08-05 Equity shares 2007-09-14 2.0 Final 2007-09-18 Equity shares 2005-08-03 0.0 Final 2005-08-05 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2023-10-10 10.0 1.0 2023-10-10

Learn More About Stocks

About THEMIS MEDICARE LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by THEMIS MEDICARE LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Themis Medicare Ltd?

Answer Field

The share price of Themis Medicare Ltd for NSE is ₹ 0 and for BSE is ₹ 0.

What is the Market Cap of Themis Medicare Ltd?

Answer Field

The market cap of Themis Medicare Ltd for NSE is ₹ 0.00 Cr. and for BSE is ₹ 0.00 Cr. as of now.

What is the 52 Week High and Low of Themis Medicare Ltd?

Answer Field

The 52 Week High and Low of Themis Medicare Ltd for NSE is ₹ 317.00 and ₹ 168.55 and for BSE is ₹ 313.65 and ₹ 168.05.

How to Buy Themis Medicare Ltd share?

Answer Field

You can trade in Themis Medicare Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Themis Medicare Ltd?

Answer Field

The 1 year returns on the stock has been 62.66%.

What is the Current Share Price of Themis Medicare Ltd?

Answer Field

Themis Medicare Ltd share price is for NSE ₹ 0 & for BSE ₹ 0 as on Dec 11 2024 12:00 AM.

What is the Market Cap of Themis Medicare Ltd Share?

Answer Field

The market cap of Themis Medicare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Dec 11 2024 12:00 AM.

What is the P/E Ratio of Themis Medicare Ltd Share?

Answer Field

As on Dec 11 2024 12:00 AM the price-to-earnings (PE) ratio for Themis Medicare Ltd share is 79.29.

What is the PB ratio of Themis Medicare Ltd Share?

Answer Field

As on Dec 11 2024 12:00 AM, the price-to-book (PB) ratio for Themis Medicare Ltd share is 31.70.

How to Buy Themis Medicare Ltd Share?

Answer Field

You can trade in Themis Medicare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Themis Medicare Ltd Share on Bajaj Broking App?

Answer Field

To buy Themis Medicare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Themis Medicare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader